Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for F4JRP8

Entry ID Method Resolution Chain Position Source
AF-F4JRP8-F1 Predicted AlphaFoldDB

45 variants for F4JRP8

Variant ID(s) Position Change Description Diseaes Association Provenance
ENSVATH12205985 18 V>I No 1000Genomes
ENSVATH00536137 63 D>A No 1000Genomes
ENSVATH06769220 63 D>E No 1000Genomes
tmp_4_12778436_C_T 72 A>V No 1000Genomes
tmp_4_12778441_G_A 74 V>M No 1000Genomes
tmp_4_12778514_G_C 98 S>T No 1000Genomes
tmp_4_12778530_T_A 103 N>K No 1000Genomes
ENSVATH00536138 118 S>G No 1000Genomes
ENSVATH00536139 137 V>A No 1000Genomes
ENSVATH06769223 149 H>R No 1000Genomes
tmp_4_12778669_T_A 150 Y>N No 1000Genomes
ENSVATH12205988 155 A>S No 1000Genomes
ENSVATH00536140 171 S>T No 1000Genomes
tmp_4_12778744_A_T 175 S>C No 1000Genomes
tmp_4_12778745_G_T 175 S>I No 1000Genomes
ENSVATH14293065 202 P>L No 1000Genomes
tmp_4_12778838_G_A 206 G>E No 1000Genomes
tmp_4_12778850_C_A 210 S>Y No 1000Genomes
tmp_4_12778892_A_T 224 N>I No 1000Genomes
tmp_4_12778909_G_A 230 V>M No 1000Genomes
tmp_4_12779104_G_A 295 A>T No 1000Genomes
tmp_4_12779132_C_A 304 A>E No 1000Genomes
tmp_4_12779230_C_T 337 P>S No 1000Genomes
tmp_4_12779258_G_A 346 S>N No 1000Genomes
ENSVATH02920711 352 V>L No 1000Genomes
tmp_4_12779611_G_A 464 G>S No 1000Genomes
tmp_4_12779788_C_A 494 S>Y No 1000Genomes
ENSVATH06769229 546 R>S No 1000Genomes
ENSVATH14293067 609 V>I No 1000Genomes
ENSVATH02920716 623 I>T No 1000Genomes
tmp_4_12780403_A_C 636 N>T No 1000Genomes
ENSVATH06769232 651 C>S No 1000Genomes
tmp_4_12780498_C_G 668 L>V No 1000Genomes
ENSVATH00536147 673 G>D No 1000Genomes
ENSVATH06769233 682 Y>C No 1000Genomes
ENSVATH00536148 712 Q>R No 1000Genomes
tmp_4_12780843_G_T 754 D>Y No 1000Genomes
ENSVATH00536149 759 S>F No 1000Genomes
tmp_4_12780927_C_T 782 R>C No 1000Genomes
ENSVATH06769235 803 A>T No 1000Genomes
ENSVATH02920718 811 P>S No 1000Genomes
tmp_4_12781162_C_T 829 P>L No 1000Genomes
tmp_4_12781272_A_C 834 Q>P No 1000Genomes
tmp_4_12781304_C_T 845 L>F No 1000Genomes
tmp_4_12781341_A_G 857 N>S No 1000Genomes

2 associated diseases with F4JRP8

[MIM: 614504]: Usher syndrome 3B (USH3B)

A syndrome characterized by progressive vision and hearing loss during early childhood. Some patients have the so-called 'Charles Bonnet syndrome,' involving decreased visual acuity and vivid visual hallucinations. USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH3 is characterized by postlingual, progressive hearing loss, variable vestibular dysfunction, and onset of retinitis pigmentosa symptoms, including nyctalopia, constriction of the visual fields, and loss of central visual acuity, usually by the second decade of life. {ECO:0000269|PubMed:22279524}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 616625]: Charcot-Marie-Tooth disease 2W (CMT2W)

An autosomal dominant, axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology

Without disease ID
  • A syndrome characterized by progressive vision and hearing loss during early childhood. Some patients have the so-called 'Charles Bonnet syndrome,' involving decreased visual acuity and vivid visual hallucinations. USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH3 is characterized by postlingual, progressive hearing loss, variable vestibular dysfunction, and onset of retinitis pigmentosa symptoms, including nyctalopia, constriction of the visual fields, and loss of central visual acuity, usually by the second decade of life. {ECO:0000269|PubMed:22279524}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • An autosomal dominant, axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology

17 regional properties for F4JRP8

Type Name Position InterPro Accession
domain NGN domain 183 - 265 IPR005100
domain KOW 273 - 300 IPR005824-1
domain KOW 425 - 452 IPR005824-2
domain KOW 477 - 522 IPR005824-3
domain KOW 601 - 628 IPR005824-4
domain KOW 712 - 739 IPR005824-5
domain KOW 988 - 1015 IPR005824-6
conserved_site Ribosomal protein L24/L26, conserved site 429 - 446 IPR005825
domain NusG-like, N-terminal 181 - 268 IPR006645
domain Spt5 transcription elongation factor, N-terminal 90 - 177 IPR022581
domain NGN domain, eukaryotic 183 - 266 IPR039385
domain Spt5, KOW domain repeat 1 277 - 314 IPR041973
domain Spt5, KOW domain repeat 2 426 - 476 IPR041975
domain Spt5, KOW domain repeat 3 477 - 527 IPR041976
domain Spt5, KOW domain repeat 4 605 - 647 IPR041977
domain Spt5, KOW domain repeat 5 711 - 758 IPR041978
domain Spt5, KOW domain repeat 6 982 - 1039 IPR041980

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
DNA polymerase III complex The DNA polymerase III holoenzyme is a complex that contains 10 different types of subunits. These subunits are organized into 3 functionally essential sub-assemblies: the pol III core, the beta sliding clamp processivity factor and the clamp-loading complex. The pol III core carries out the polymerase and the 3'-5' exonuclease proofreading activities. The polymerase is tethered to the template via the sliding clamp processivity factor. The clamp-loading complex assembles the beta processivity factor onto the primer template and plays a central role in the organization and communication at the replication fork.
DNA replication factor C complex A complex that loads the DNA polymerase processivity factor proliferating cell nuclear antigen (PCNA) onto DNA, thereby permitting processive DNA synthesis catalyzed by DNA polymerase. In eukaryotes the complex consists of five polypeptides.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

3 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
DNA-directed DNA polymerase activity Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1); the synthesis of DNA from deoxyribonucleotide triphosphates in the presence of a DNA template and a 3'hydroxyl group.

2 GO annotations of biological process

Name Definition
DNA repair The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
DNA-templated DNA replication A DNA replication process that uses parental DNA as a template for the DNA-dependent DNA polymerases that synthesize the new strands.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P06710 dnaX DNA polymerase III subunit tau Escherichia coli (strain K12) PR
P35249 RFC4 Replication factor C subunit 4 Homo sapiens (Human) PR
Q99J62 Rfc4 Replication factor C subunit 4 Mus musculus (Mouse) PR
Q9D0F6 Rfc5 Replication factor C subunit 5 Mus musculus (Mouse) PR
10 20 30 40 50 60
MGETRRHSVD VPITRTLVAL RRVRSLRDPC TTSMSKFASL LDNVKWETGS NNGISLQFVE
70 80 90 100 110 120
HADDACKAAA DAPVGLIPFG SYSIMEELES GCDLHKLSSK VINVEGDACS RSSERSCSDL
130 140 150 160 170 180
SVKGRDLACN APSISHVEEA GSGGRYRTHY STKLASSVGE YGSRLGSPMN STNHSYYGDE
190 200 210 220 230 240
DVDFDSQSNR GCGITYCWSR TPRYRGSNQS SDVEEYPLLP GNGNGESDVV TPSHEVLSRS
250 260 270 280 290 300
LSQKFRPKSF DELVGQEVVV KCLLSTILRG RITSVYLFHG PRGTGKTSTS KIFAAALNCL
310 320 330 340 350 360
SQAAHSRPCG LCSECKSYFS GRGRDVMETD SGKLNRPSYL RSLIKSASLP PVSSRFKVFI
370 380 390 400 410 420
IDECQLLCQE TWGTLLNSLD NFSQHSVFIL VTSELEKLPR NVLSRSQKYH FSKVCDADIS
430 440 450 460 470 480
TKLAKICIEE GIDFDQGAVD FIASKSDGSL RDAEIMLDQL SLLGKRITTS LAYKLIGVVS
490 500 510 520 530 540
DDELLDLLDL AMSSDTSNTV IRARELMRSK IDPMQLISQL ANVIMDIIAG NSQESSSATR
550 560 570 580 590 600
LRFLTRHTSE EEMQKLRNAL KILSDAEKHL RASKNQTTWL TVALLQLSNT DSSSFATDEN
610 620 630 640 650 660
GRNQINKDVE LSSTSSGCPG DVIKSDAEKG QERNCNETVE SVWKTVTDLC CSDSLKRFLW
670 680 690 700 710 720
KRGRLTSLTV DKGVAIAELE FYTPQHVARA EKSWKLIADS FQSVLGCNVE IQMNLVISAC
730 740 750 760 770 780
SPPKSAKAAA SLFFGLFSCS RRMLHKSYLT TRTDSDCASE KPAVTNSLRS CQGNVLRARS
790 800 810 820 830 840
VRSSANASSR MSCSSDQGDA TSAMCTPHIP PGEKRPEDDT DVLCWKKTPL GKGQSETQNS
850
KSSRLIGRVL PCSTAAN